Broot Lab Co., Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Broot Lab Co., Ltd. - overview

Established

2020

Location

Busan, -, South Korea

Primary Industry

Materials

About

Broot Lab Co. , Ltd. engages in the research and development of microalgae, producing functional biomaterials for various industries, particularly in health supplements and eco-friendly products. Broot Lab Co.


, Ltd. specializes in microalgae research with a focus on functional biomaterials. Founded in 2020, in Busan, South Korea, the company raised KRW 1 billion in a funding round on February 12, 2025, with funding from Smart Study Ventures and Vine Ventures. The CEO is Oh-soo Na, who has a background in innovative research ventures.


The company has completed a total of 1 deal to date. Broot Lab Co. , Ltd. specializes in the research and development of microalgae, aiming to produce functional biomaterials that cater to various industries.


The company focuses on harnessing the unique properties of microalgae for applications in health supplements and other bio-based products. These offerings are designed to address the growing demand for sustainable and health-oriented solutions in markets such as nutraceuticals and cosmetics. Their customer base includes manufacturers and distributors looking to enhance their product lines with innovative, eco-friendly ingredients. Bioresearch operations extend beyond domestic borders, targeting international markets in Asia, Europe, and North America, where there is an increasing trend towards natural and functional ingredients.


Broot Lab Co. , Ltd. generates revenue through B2B transactions, primarily partnering with retailers and wholesalers in the health supplement sector. The company engages in direct sales of its proprietary formulations derived from microalgae to various clients.


Transactions typically occur through negotiated contracts that outline specific quantities and pricing terms based on the client's needs. The company’s revenue is driven by the consistent demand for these innovative biomaterials in the health and wellness market. Broot Lab Co. , Ltd.


plans to utilize the recent KRW 1 billion raised in February 2025 to enhance its product offerings and expand market reach. The company is developing new products aimed at addressing the demand in health and wellness sectors, targeting launch phases within the next year. Additionally, Broot Lab is focused on expanding its operations into Asia, Europe, and North America by the end of 2026, leveraging its existing partnerships and funding to support these initiatives.


Current Investors

Smart Study Ventures, Vine Ventures, Y&ARCHER

Primary Industry

Materials

Sub Industries

Biomaterials

Website

www.brootlab.co.kr/

Verticals

Research (Non-Medical)

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Broot Lab Co., Ltd. - financials

Fiscal Year EndedDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023
Revenue (USD)----
% Revenue Growth (YoY)----
EBITDA (USD)----
Operating Income (USD)(2,994,000)---
Operating Margin----
% EBITDA Margin----
NET Income (USD)(2,984,000)---
% Net Margin----

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.